Exercise-based rehabilitation programs significantly improved VO2 peak (ES 0.765) and enhanced cardiovascular and respiratory functions in post-COVID-19 patients compared to control groups.
Systematic Review (n=291)
Do exercise-based rehabilitation programs improve cardiac and respiratory functions in COVID-19 patients?
291 adult post-COVID-19 survivors without pre-existing cardiopulmonary conditions across 5 randomized controlled trials evaluating exercise rehabilitation.
Exercise-based rehabilitation programs (including high intensity interval training [HIIT])
Control group
Cardiac and respiratory functions (including VO2 peak, maximum heart rate, left ventricular mass, maximum voluntary ventilation, FEV1, and FVC)surrogate
Exercise-based rehabilitation programs significantly improve cardiac and respiratory functions, such as VO2 peak and left ventricular mass, in post-COVID-19 patients.
Standardized Mean Difference: 0.765 (95% CI 0.391–1.139)
Introduction: Coronavirus disease 2019 (COVID-19) survivors have suffered from long-term impacts of the disease. Many survivors are experiencing persistent cardiac and respiratory complications. Some studies have shown that exercise-based rehabilitation plays a critical role in the recovery of post-COVID-19 patients in order to minimize complications such as dyspnea, breathlessness, and heart failure. Objective: The objective of this study was to evaluate the effectiveness of exercise-based rehabilitation programs to improve cardiac and respiratory functions in COVID-19 patients. Methodology: An extensive search of literature was conducted on PubMed, Cochrane Central Register of Controlled Trials, and TRIP databases using the following keywords and Boolean operators: High intensity interval training (HIIT) OR rehabilitation OR COVID-19 OR exercise AND long COVID. Randomized controlled trials (RCTs) published in the English language from 2020 to 2024 were included in the study. Full-text articles were reviewed and Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines were implemented during this systematic review. Patients who had pre-existing cardiac and respiratory complications were excluded from the study. Results: This systematic review included 5 RCTs involving 291 participants. The rehabilitation (intervention) groups showed notable improvements in VO2 peak with pooled data (ES = 0.765, SE = 0.193, 95% confidence interval CI 0.391, 1.139). The mean difference (MD) for VO2 peak was 2.42, maximum, heart rate (HR max) increased (MD = 5.33), and the left ventricular mass increased by MD = 6.8 (95% CI: 0.8; 12.8 g; P = 0.029) indicating enhanced cardiovascular conditioning and function. Maximum voluntary ventilation (MD = 5.3) improved respiratory endurance along with an increased stability in FEV1 and FVC. In addition, a drastic improvement in the ventilatory efficiency and breathing patterns was noted, thus reducing perceived dyspnea. HIIT intervention: Two participants showed a reduction in their predicted residual volume % (8%) and total lung capacity. In comparison, the control group showed no significant improvement. Conclusion: Exercise-based rehabilitation programs have shown improvement in cardiac and respiratory functions by decreasing symptoms such as dyspnea, palpitations, and failure. By integrating such rehabilitation programs into post-COVID care, long-term recovery can be significantly improved.
Building similarity graph...
Analyzing shared references across papers
Loading...
Roma Sharma
Navita Jatain
Krishna Dodia
Global Journal of Medical Pharmaceutical and Biomedical Update
Building similarity graph...
Analyzing shared references across papers
Loading...
Sharma et al. (Fri,) conducted a systematic review in Post-COVID-19 syndrome (Long COVID) (n=291). Exercise-based rehabilitation programs vs. Standard care or no specific exercise was evaluated on VO2 peak (ES 0.765, 95% CI 0.391, 1.139). Exercise-based rehabilitation programs significantly improved VO2 peak (ES 0.765) and enhanced cardiovascular and respiratory functions in post-COVID-19 patients compared to control groups.
synapsesocial.com/papers/6a20fd3f064f8ffe0932ff28 — DOI: https://doi.org/10.25259/gjmpbu_48_2024